DMD Therapeutics
Latest round
- Seed
Last raised
- Feb 2017
Total raised
- $0.4M
Investors
- 3
About DMD Therapeutics
Founded in 2015 and based in the US, DMD Therapeutics Inc. is a biotechnology firm, providing treatment for a genetic disease, Duchenne muscular dystrophy.
Who invested in DMD Therapeutics
3 investors across 1 round
See all investors in DMD Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Feb 24, 2017
Amount
$0.4M
Investors
Questions about DMD Therapeutics
Who invested in DMD Therapeutics?
DMD Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DMD Therapeutics raised?
DMD Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did DMD Therapeutics last raise money?
DMD Therapeutics's most recent round on record is a Seed, in Feb 2017.
What does DMD Therapeutics do?
Founded in 2015 and based in the US, DMD Therapeutics Inc.
Where is DMD Therapeutics headquartered?
DMD Therapeutics is headquartered in Seattle, US.
Which VCs invest in companies like DMD Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at DMD Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like DMD Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.